Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Toll-like receptor 4

  • You have access
    TU-100 Antagonizes the M2 Polarization Phenotype of Macrophages in the Tumor Microenvironment by Suppressing the TLR4/NF-GraphicB/STAT3 Axis
    SHUHAI CHEN, YUJI MORINE, YU SAITO, SHINICHIRO YAMADA, HIROKI TERAOKU, TETSUYA IKEMOTO and MITSUO SHIMADA
    Anticancer Research May 2023, 43 (5) 1985-1992; DOI: https://doi.org/10.21873/anticanres.16359
  • You have access
    Effects of Kumaizasa (Sasa senanensis) Leaf Extract on Innate Immune Regulation in HEK293 Cells and Macrophages
    KEISUKE SATO, RYOSUKE TATSUNAMI, AKIFUMI NAKATA, KEN-ICHI KOMATSU, SHINJI HARAKAWA, TAKAKI NEDACHI, KAORU HAKETA, HIROYUKI INAGAWA and KOJI WAKAME
    Anticancer Research August 2021, 41 (8) 4093-4100; DOI: https://doi.org/10.21873/anticanres.15212
  • You have access
    Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer
    YOSHITO KUSUHARA, KEI DAIZUMOTO, KAICHI KAWAI, KENTO HIRAYAMA, MINORU KOWADA, TERUMICHI SHINTANI, YAYOI FUKUHARA, TSOGT-OCHIR DONDOO, KEISUKE OZAKI, MEGUMI TSUDA, TOMOYA FUKAWA, HIROYOSHI NAKATSUJI, YOSHIMI BANDO, HISANORI UEHARA, TOMOHARU FUKUMORI, MASAYUKI TAKAHASHI and HIRO-OMI KANAYAMA
    Anticancer Research February 2019, 39 (2) 703-711; DOI: https://doi.org/10.21873/anticanres.13166
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire